Curriculum Vitae

Corey Benjamin Moore · MBBS PhD MPH MHM BSc (Hons)

Profile

A medical doctor with an unusual combination of clinical, research and engineering experience: phase I and IV clinical trials, population-scale immunogenetics, communicable disease control, health policy evaluation and thirty years of commercial software development.

  • Public health training and experience in policy and program evaluation, critical appraisal, epidemiology, biostatistics and communicable disease control.
  • Publications in Science, Nature and The Lancet, with over 5,500 verified citations.
  • Chief or named investigator on one international and two national research grants totalling $23.1 million.
  • Research collaborations with Oxford, Harvard, GlaxoSmithKline and Microsoft Research.
  • Supervised, mentored and taught students, scientists, nurses, clinicians and professors.
  • Responsible for company, customer and patient intellectual property and confidentiality.

Employment

2023 –

Resident Medical Officer

WA Country Health Service
  • Leave relief doctor at Albany Hospital to refresh clinical skills.
2023

Public Health Officer Trainee / Advanced Trainee in Public Health

Centre for Epidemiology and Evidence, NSW Ministry of Health
  • Supported the executive and statutory roles of the Minister for Health with expert medical advice and epidemiological analyses.
  • Received a personal request from the Chief Health Officer to work at the Ministry of Health, and produced ad-hoc reports at their request.
  • Led an evaluation into the impact of a policy change at the request of the Chief Health Officer.
  • Identified data quality issues and proactively automated data processes, analyses and reporting.
  • Critically evaluated the quality of an economic analysis in an All-of-Government program and made recommendations to the director.
  • Developed high-level dashboards to help decision makers monitor and assess research grants.
2022

Public Health Registrar

Public Health Unit, Nepean Blue Mountains Local Health District
  • Developed processes to monitor and manage COVID-19 cases and infection control in aged care facilities.
  • Initiated and performed an evaluation of the COVID-19 response in aged care facilities within and between districts.
  • Declared COVID-19 outbreaks and chaired multi-governmental management meetings.
  • Enforced environmental health regulations and provided advice on communicable diseases.
  • Audited infection control measures for a COVID-19 outbreak in a prison.
2021

Public Health Registrar

Public Health Unit, Sydney Local Health District
  • Proactively sought a secondment to the public health unit within days of the first community transmission of the Delta variant of COVID-19.
  • Collaborated with multiple stakeholders on strategies to reduce COVID-19 transmission in NSW, including real-time updates to community health practitioners and direct work with the public.
  • Improved processes and developed an application to manage and report on COVID-19 cases and contacts. The application was recognised by peers and received an award from the Chief Executive.
  • Formed a research collaboration between the district and the University of Sydney, resulting in publications on socioeconomics, public health measures and COVID-19 outcomes.
2020

Public Health Registrar, Community Paediatrics

Sydney Local Health District
  • Mentored and collaborated with colleagues and Masters students in studies resulting in six peer-reviewed publications.
  • Delivered public health teaching to Advanced Trainees in Paediatrics.
2017 – 2020

Medical Intern, then Resident Medical Officer

Royal Perth Hospital; Sir Charles Gairdner Hospital
  • Rotations in emergency, general medicine, general surgery, orthopaedics, rehabilitation, neurosurgery, neurology, urology, respiratory, oncology and night cover across nine hospitals.
  • Participated in MET calls, assessed deteriorating patients and liaised with consultants on patient management.
  • Screened and monitored participants in phase I clinical trials as per study protocols.
  • Built a research collaboration with Nobel Laureate Professor Barry Marshall.
  • Received an Employee Recognition Award.
2018 –

Director, Moore Foundation Ltd

Albany, WA
  • Established an ACNC-registered charity to identify and fund underprivileged medical and university students in the Philippines.
2006 –

Director, eBioSys Pty Ltd

Perth, WA
  • Designed, developed and marketed eLab, a laboratory information management system complying with FDA regulations on electronic records.
2002 – 2006

Senior Research Scientist

Centre for Clinical Immunology and Biomedical Statistics / Institute for Immunology and Infectious Diseases, Royal Perth Hospital & Murdoch University
  • Published 33 articles in peer-reviewed journals including Nature, Science and The Lancet.
  • Author on 30 oral presentations, 5 poster presentations, 4 patents and 18 media features.
  • Formed collaborations with Oxford University, Harvard University, GlaxoSmithKline and Microsoft Research.
  • Chief investigator on projects receiving $23,124,955 from NH&MRC, the Bill and Melinda Gates Foundation, Microsoft, NIH and GlaxoSmithKline.
  • Developed a methodological approach to studying host–pathogen interactions, with implications for vaccine design.
  • Discovered an HLA association with susceptibility to a life-threatening drug hypersensitivity reaction, changing international guidelines and testing of patients with HIV.
1996 – 2006

Database Architect and Administrator Part time

Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital
  • Designed the WA HIV clinical database and managed it for ten years.
  • Developed processes to collate data from disparate hospital systems to produce patient reports for the management of all HIV patients in WA.
1988 –

Director, HerbiGuide Pty Ltd

Albany, WA
  • Founded an agricultural software company providing pesticide and environmental advice within APVMA regulatory guidelines.
  • Won several contracts with the Department of Agriculture and community organisations.
  • Awarded First Prize in the CompuFarm Competition by the Hon. Simon Crean MP, and the Encouragement Award at the Australian Farm Software Competition, Sydney Royal Show.

Education and qualifications

2020

Master of Health Management (Excellence)

University of New South Wales
2019

Master of Public Health (Excellence)

University of New South Wales
  • Publications in peer-reviewed journals on universal healthcare policy, smallpox, ethics and aged care policy.
2012 – 2016

Bachelor of Medicine, Bachelor of Surgery (MBBS)

Australian National University
  • ANU Medical School Scholarship — top ranked student on entry.
  • Rural Australia Medical Undergraduate Scholarship, National Rural Health Alliance and Department of Health and Ageing.
  • Won the first- and third-year population health prizes.
  • Best Grand Rounds Presentation, Goulburn Base Hospital.
  • Selected for the Indigenous stream, with training in a remote Aboriginal community.
2011

Doctor of Medicine (partial)

Cebu Institute of Medicine, Philippines
  • Six months studying medicine in the developing world before enrolling in medicine in Australia.
2008 – 2010

Commercial Pilot's Licence

Great Southern Aviation
1997 – 2002

Doctor of Philosophy (Immunology and Biomedical Statistics)

Royal Perth Hospital & Murdoch University
  • Thesis rated in the top 5% of theses submitted to Cambridge University.
  • Awarded best science publication by a young scientist in Western Australia.
  • Contributed to my supervisor receiving the award for Best Scientist in WA.
1996

Bachelor of Science (First Class Honours)

Murdoch University
  • Scholarship from the Immunogenetics Research Foundation.
1993 – 1995

Bachelor of Science (Computer Science)

University of Western Australia
  • First Prize, Best Software Competition, Institute of Electrical and Electronic Engineers.

Research grant support As chief or named investigator

Year Funder and project Amount (AUD)
2005–08 Bill and Melinda Gates Foundation — HIV adaptation to HLA-restricted immune responses in diverse human populations: application to HIV vaccine design $12,740,000
2006–10 NH&MRC Program Grant ID 384702 — Interactions between adaptable pathogens, drugs and the human host $5,727,327
2007 Western Australian Centres of Excellence Infrastructure Grant $2,300,000
2000–03 GlaxoSmithKline (UK) $1,613,320
2003–05 NH&MRC Project Grant ID 237412 — Characterisation of polymorphism in HIV-1 sequence: investigation of viral escape from HLA-restricted immune responses $425,250
2005 Microsoft Corporation $130,000
1997–2002 Australian Postgraduate Award; CCIBS Post-graduate Scholarship $110,000
2011–16 Department of Agriculture and Food WA; R&D Tax Incentive; South Coast NRM — image analysis for pest detection, quadcopter and autonomous vehicle development, environmental weed control $56,050
1996–2003 Raine Research Foundation; Murdoch University Special Research Grant and travel grant; Honours Research Scholarship $23,008
Total $23,124,955

Publications Citation counts verified against OpenAlex, September 2026

Counts shown are from OpenAlex and total 5,531 across 26 indexed works. Indexes that also count theses, books and grey literature report higher figures — a 2023 Google Scholar count gave 6,752. Ten entries are not indexed or are not yet published.

  1. A review of the impact of community integrated care programs on hospital presentations and activity Fotheringham P, Moore C, Mukumbang F, Uribe G, Montgomery A, Maitland-Scott I, Ionniades S, Eastwood JE In preparation
  2. What do we mean by social care in the global dialogue surrounding integrated care? A narrative review Uribe G, Mukumbang FC, Moore C, Gillespie J, Woolfenden S, Ostojic K, Haber P, Eastwood J, Huckel-Schneider C Journal of Integrated Care Submitted
  3. Australian HIV Observational Database collaboration study Petoumenos K, Austin D, Baker D, et al. (Australian HIV Observational Database) See 2023 CV for full citation count unavailable
  4. Australian HIV Observational Database collaboration study Rooney P, Taylor S, Couldwell D, et al. (Australian HIV Observational Database) See 2023 CV for full citation count unavailable
  5. The impact of contextual socioeconomic and demographic characteristics of residents on COVID-19 outcomes during public health restrictions in Sydney, Australia Uribe G, Moore C, Giannopoulos C, Liu H, Mukumbang FC, Quinn E, Cunich M, Katz I, Page A, Wolfenden S, Gillespie J, Haber P, Wilson A, Gupta L, Eastwood J, Huckel Schneider C Australian and New Zealand Journal of Public Health 2025 49(2) 3 citations
  6. Unpacking the design, implementation and uptake of community-integrated health care services: a critical realist synthesis Mukumbang FC, De Souza D, Liu H, Uribe G, Moore C, Fotheringham P, Eastwood JG BMJ Global Health 2022 7:e009129 14 citations
  7. Sydney Local Health District's Integrated Response to the COVID-19 Pandemic: A Descriptive Study Liu D, Liu H, Blunden L, Gupta L, Moore C, Nilsson S, Parcsi L, Shaw M, Anderson T, Eastwood J International Journal of Integrated Care 2022 22(3):23 4 citations
  8. Understanding for whom, how and why Sydney Local Health District's integrated response was effective in addressing COVID-19: a critical realist qualitative study Liu H, Liu D, Moore C, Parcsi L, Mukumbang F, De Souza D, Shaw M, Blunden L, Anderson T, Eastwood J International Journal of Integrated Care 2022 22(1):13 7 citations
  9. Audit of the Sydney Local Health District Public Health Unit notification and contact tracing system during the first-wave of COVID-19 Jain N, Moore CB, Quinn E, Liu H, Liu D, Heaton M, Gehlot P, Dhakal Y, Gupta L, Hogbin R, Eastwood JG Australian and New Zealand Journal of Public Health 2021 45(5):526-530 6 citations
  10. Consumer Directed Care aged care reforms in Australia since 2009: A retrospective policy analysis Moore CB Health Policy 2021 125:577-581 40 citations First author
  11. Ebola, quarantine, and the need for a new ethical framework Moore CB Journal of Medical Ethics and History of Medicine 2020 13(9) count unavailable First author
  12. Pathophysiology of Irritable Bowel Syndrome: A Review Moore CB Journal of Gastroenterology, Hepatology and Endoscopy 2019 4(4):1070 count unavailable First author
  13. Smallpox - leaving its mark on public health Moore CB International Journal of Community Medicine and Public Health 2019 6(11):5013-5014 1 citations First author
  14. The Philippines' Universal Healthcare Policy (Kalusugan Pangkalahatan) and the poor Moore CB Philippine Journal of Public Policy 2019 6(11):1-10 count unavailable First author
  15. An intervention program for general practice for the prevention of childhood bullying Moore C Medical Student Journal of Australia 2014 5(2):41-49 First author
  16. Government policy on financial assistance to medical students discourages medical research Moore C Medical Student Journal of Australia 2012 4(2):42 First author
  17. Life in the developing world as a foreign medical student Moore C Medical Student Journal of Australia 2012 4(2):52-54 First author
  18. Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS Gabutero E, Moore C, Mallal S, Stewart G, Williamson P AIDS 2007 21(1):65-9 13 citations
  19. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes Frahm N, Kiepiela P, Adams S, ... Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, Brander C Nature Immunology 2006 7(2):173-8 227 citations High impact
  20. Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation Pace C, Keller J, Nolan D, James I, Gaudieri S, Moore C, Mallal S Journal of Virology 2006 80(18):9259-9269 134 citations
  21. Selective escape from CD8+ T-cell responses represents a major driving force of HIV-1 sequence diversity and reveals constraints on HIV-1 evolution Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, ... Mallal SA, Walker BD Journal of Virology 2005 79(21):13239-49 340 citations
  22. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response Feeney ME, Tang Y, Pfafferott K, ... Moore C, Mallal S, ... Altfeld M, Walker BD, Goulder PRJ Journal of Immunology 2005 174(12):7524-7530 110 citations
  23. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt C, Mallal S, Christiansen F Genes and Immunity 2005 6(8):683-690 128 citations
  24. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1 John M, Moore CB, James IR, Mallal SA Antiviral Therapy 2005 10(4):551-555 39 citations
  25. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA Leslie A, Kavanagh D, Honeyborne I, ... Moore C, Mallal S, ... Goulder P Journal of Experimental Medicine 2005 240 citations
  26. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S AIDS 2004 19(1):97-99 317 citations
  27. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA Kiepiela P, Leslie AJ, Honeyborne I, ... Moore C, ... James I, Mallal S, ... Goulder PJR Nature 2004 432(7018):769-775 852 citations High impact
  28. Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy Nolan D, Moore C, Castley A, Sayer D, Mamotte C, John M, James I, Mallal S AIDS 2003 17(1):121-123 3 citations
  29. Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients John M, McKinnon EJ, James IR, Nolan DA, Herrmann SE, Moore CB, White AJ, Mallal SA JAIDS 2003 113 citations
  30. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA Science 2002 296(5572):1410-1411 746 citations First author High impact

    Core finding of my PhD: HIV adapts to the HLA genotypes prevalent in a host population, with direct implications for vaccine design.

  31. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT The Lancet 2002 359(9308):727-732 1,387 citations High impact

    The analysis behind this paper changed international HIV prescribing guidelines: HLA-B*5701 screening before abacavir is now standard of care worldwide.

  32. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA AIDS 2001 15(6):795-797 263 citations
  33. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection Mallal SA, John M, Moore CB, James IR, McKinnon EJ AIDS 2000 14(10):1309-1316 521 citations
  34. Control of HIV replication by CTL responses John M, Rowland-Jones S, Moore C, Mallal S Journal of HIV Therapy 2000 4(1):1-7
  35. Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype Price P, Calder DM, Witt CS, Allcock RJN, Christiansen FT, Davies GR, Cameron PU, Rogers M, Baluchova K, Moore CB, French MA European Journal of Oral Sciences 1999 23 citations
  36. The value of dual-energy X-ray absorptiometry (DEXA) scans in monitoring HIV patients on protease inhibitors Roff G, McCarthy M, Moore C, Mallal S Nuclear Medicine Communications 1999 20(4):403-404

Presentations

30 oral presentations and 15 poster presentations at national and international conferences, including the Conference on Retroviruses and Opportunistic Infections (Boston and Seattle), the International AIDS Conference (Durban), the International Congress of Histocompatibility and Immunogenetics (Seattle), the British Society for Immunology (Harrogate) and NSW Health Epi Grand Rounds.

Selected oral presentations 30 total
  1. Moore CB. Public Monkey Business at Sexual Health. Nepean Hospital Grand Rounds. Penrith; 11 August 2022.
  2. Moore CB, Truman G, Mulvey C, Glasgow K. The sticky date: Hepatitis A in a 15-year-old male related to an international foodborne outbreak. NSW Health Epi Grand Rounds. Sydney; 7 April 2022.
  3. Soultani M, Moore C, Armstrong R, Wang Y, Quinn E, Gupta L. Driving through or dropping in: how Sydney turned up for COVID-19 testing. Communicable Diseases and Immunisation Conference. Sydney; 20 June 2022.
  4. Jojic V, Moore CB, John M, Heckerman D, Mallal SA. HLA optimization of a HIV vaccine. 12th Conference on Retroviruses and Opportunistic Infections. Boston; 10–14 February 2005.
  5. Moore CB. Experiences with Aborigines from Central Australia. Goulburn Base Hospital Grand Rounds. Goulburn; 11 September 2014.
  6. Moore C, John M, James I, Mallal SA. Characteristic mutations in HIV-1 reverse transcriptase sequence encoding HLA class I restricted CTL epitopes: evidence of HIV-1 CTL escape at a population level. 24th Australian and South East Asian Tissue Typing Association Conference. Perth; 30 November–3 December 2000.
  7. Moore C, John M, Mallal S. Costs associated with management of lipodystrophy syndrome. Fourth International Cohorts Meeting. Marbella, Spain; 30–31 March 2000.
  8. Moore C, Herrmann S, Mallal S, Watts GF, Lenzo N, French M, van Bockxmeer F. Peripheral lipodystrophy, dyslipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Annual Scientific Meeting of the Australian Diabetes Society. Perth; 26–28 August 1998.

Full list of 30 oral and 15 poster presentations available in the detailed CV on request.

Patents

2006

Association-based epitome design

US 2006/0160070 A1 — Mallal SA, Heckerman DE, Jojic N, Jojic V, Meek CA, Moore CB, Kadie CM
2011

Association-based predictions of pathogen characteristics

US 8,000,900 B2 — Heckerman DE, Mallal SA, Kadie CM, Moore CB, Jojic N
  • With the patent above, describes methods for determining the likelihood that a region of a foreign genome is immunogenic, based on polymorphisms in that genome across a host population.
2003

Method for identification and determination of hypersensitivity of a patient to abacavir

WO 03/068985; US 2006/046267; EP 1 472 367; CA 2 475 784 — Inventor: Mallal S
  • Resulted from my analysis showing a significant association between HLA-B17 (a subtype of B57) and abacavir hypersensitivity. Led to commercial flow cytometry and SSP genetic diagnostic kits with One Lambda Corporation and Becton-Coulter.
2002

Method for identification and development of therapeutic agents

WO 03/035097; US 2006/257865; EP 1 438 064; CN 1602202; CA 2 464 366 — Inventor: Mallal S
  • A result of my PhD. Describes methods to identify which amino acids of a foreign genome mutate in vivo to avoid host immune recognition, and how to use that to design therapeutics and vaccines.

Awards and prizes

2021 Recognition of Excellence in COVID-19 Response, Highly Commended — Innovation and Excellence Awards, Sydney Local Health District
2020 Employee Recognition Award, Osborne Park Hospital
2014 Best Grand Rounds Presentation, Goulburn Base Hospital; The Population Health Group Prize, ANU Medical School
2013–15 Rural Australia Medical Undergraduate Scholarship, National Rural Health Alliance and Department of Health and Ageing
2012–15 ANU Medical School Scholarship — top ranked student on entry; The Population Health Prize; Indigenous Stream
2003 Best Science Publication in Western Australia, Raine Research Foundation
1997 Australian Postgraduate Award, Murdoch University and University of Western Australia
1996 First Prize, Western Australian Best Software Competition, Institute of Electrical and Electronic Engineers; Honours Scholarship, Immunogenetics Research Foundation
1992 Winner, Western Australian Young Achiever of the Year (Regional Category, inaugural) — Channel 10 and Wesfarmers
1992 First Prize, CompuFarm Competition — Commonwealth Department of Primary Industries and Energy and the Commonwealth Development Bank. International competition for educational software teaching good farming practice. Also: Encouragement Award, Australian Farm Software Competition, Sydney Royal Show
1991 International Science School Scholarship, University of Sydney

Memberships

2021 – Research Affiliate, Menzies Centre for Health Policy & Economics, University of Sydney
2020 – Sydney Institute for Women, Children and their Families
2013 – Australian Medical Association
2009 – Albany Aero Club
2000 Australian Institute of Agricultural Science and Technology

Technical skills

Languages

C#, TypeScript, JavaScript, Java, SQL, C++, Visual Basic, Delphi/Pascal

Statistics

R, SAS, SPSS, S-Plus

Databases

Microsoft SQL Server, SQLite, Access, Centura/Gupta/SQLBase, Paradox

Tools

Visual Studio, VS Code, Git, Subversion, NUnit, FxCop, Unreal Engine 5

Platforms

Amazon Web Services, SharePoint, Exchange Server, IIS, Virtual PC

Domain software

Applied Biosystems SeqScape, EndNote/Reference Manager, eBioSys eLab, HerbiGuide

Media 52 features, 1988–2015

Selected media coverage 52 total
  1. Saunders C. High-flying UWA graduate works with Nobel Laureate. MeDeFacts 21(1):11. March 2015.
  2. Swan N. Gene test for HIV drug toxicity. Health Minutes, ABC Health & Wellbeing. 11 July 2005.
  3. Mallal SA, Martin A, Swan N. Gene testing for safe prescribing of HIV drug. The Health Report, ABC Radio National. 4 July 2005.
  4. Gates Research Grant. Channel 9 TV News. c. 2005.
  5. Raine doubles the winnings. UWA News 22(10):6. 28 July 2003.
  6. Kingman S. Population data analysis holds lessons for vaccine designers. BioWorld International 7(23):1. 5 June 2002.
  7. Swan N. Important new work on AIDS. The Health Report, ABC Radio National. 3 June 2002.
  8. Mascolini M. HIV diversity driven by viral response to HLA. International AIDS Society. 31 May 2002.
  9. Stewart J. New AIDS treatment. AM, ABC Radio. 24 May 2002.
  10. Dortch E. Computer whiz taps HIV secrets. The West Australian. 24 May 2002.
  11. Montgomery B. DNA treatment tailored for HIV. The Australian. 24 May 2002.
  12. McKinney M. HIV changes to hide from immune cells. Reuters Health. 23 May 2002.
  13. Meredith H. Father and son help to cultivate clever country — overseas interest in home-grown software HerbiGuide. The Australian. 11 February 1992 (lead story, Computers & High Technology section).
  14. Thornton C. Software down on the farm. The Australian. 24 March 1992.
  15. Lynch A. Game helps cockies count coffers. The Weekly Times. 8 January 1992.
  16. Winners show that our future's in good hands. WA Young Achiever Awards feature. The Sunday Times. 29 November 1992.
  17. Carbon D. Computer game is $20,000 winner. The Countryman. 28 November 1991.
  18. Albany boy shares $20,000 game prize. The West Australian. 28 November 1991.
  19. Chambers AJ. Book review: HerbiGuide. Plant Protection Quarterly 6(2):91. 1991.
  20. Bailey J. HerbiGuide. Your Computer. August 1990.

A further 32 features across print, radio and television, 1988–2015, are listed in the detailed CV.

Referees

Referees, including medical supervisors at Sydney Local Health District and NSW Health, are available on request. Their contact details are not published here.